Effects of lowering LDL cholesterol on progression of kidney disease.
Lowering LDL cholesterol reduces the risk of developing atherosclerotic events in CKD, but the effects of such treatment on progression of kidney disease remain uncertain. Here, 6245 participants with CKD (not on dialysis) were randomly assigned to simvastatin (20 mg) plus ezetimibe (10 mg) daily or...
Autores principales: | Haynes, R, Lewis, D, Emberson, J, Reith, C, Agodoa, L, Cass, A, Craig, J, de Zeeuw, D, Feldt-Rasmussen, B, Fellström, B, Levin, A, Wheeler, D, Walker, R, Herrington, W, Baigent, C, Landray, M |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
2014
|
Ejemplares similares
-
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
por: Storey, B, et al.
Publicado: (2017) -
The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection.
por: Herrington, W, et al.
Publicado: (2014) -
Cost-effectiveness of lowering LDL cholesterol with statins and ezetimibe in chronic kidney disease
por: Mihaylova, B, et al.
Publicado: (2019) -
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
por: Baigent, C, et al.
Publicado: (2011) -
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
por: Baigent, C, et al.
Publicado: (2011)